Abstract 2964: Pharmacological inhibition of WIP1 by GSK2830371 sensitizes AML cells to MDM2 inhibitor Nutlin-3a
Maria Chiara Fontana(Istituto Oncologico Romagnolo), Giovanni Martinelli(University of Bologna), Anna Ferrari(University of Bologna), Andrea Ghelli Luserna di Rorà(Fondazione Pisa), Giovanni Marconi(University of Bologna), Jacopo Nanni(Istituto di Ematologia di Bologna), Matteo Bocconcelli(University of Bologna), Cristina Papayannidis(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Giorgia Simonetti(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Ilaria Iacobucci(St. Jude Children's Research Hospital), Antonella Padella(University of Bologna), Michèle Cavo(Unknown), Enrica Imbrogno(University of Bologna), Maria Teresa Bochicchio(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Martina Pazzaglia(University of Bologna), Simona Soverini(University of Bologna)
Cited by 0
Related Papers
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k